Humanoid robot startup Apptronik has now raised $935M at a $5B+ valuation
Apptronik has sold another $520 million in a Series A extension to existing and new investors like Google and Mercedes-Benz.
Can the creator economy stay afloat in a flood of AI slop?
On the latest episode of Equity, we debated what’s next for the creator economy, and whether there will be any room for the next generation of creators to stand out.
Others
Meridian raises $17 million to remake the agentic spreadsheet
A new company called Meridian.AI has emerged from stealth with an IDE-based approach to agentic financial modeling.
You Don’t Need Silicon Valley Funding to Start a Business — and These Founders Are Proving It
Founders across emerging and regional markets are building world-class companies without Silicon Valley’s capital advantage. Here’s how.
Samsung to hold its Galaxy S26 event on February 25
Samsung is going to launch S26 lineup just before Mobile World Congress (MWC).
With co-founders leaving and an IPO looming, Elon Musk turns talk to the moon
According to The New York Times, which reports that it heard the meeting, Musk told employees that xAI needs a lunar manufacturing facility, a factory on the moon that will build AI satellites and fling them into space via a giant catapult.
OpenAI policy exec who opposed chatbot’s “adult mode” reportedly fired on discrimination claim
The executive has denied the allegation that she engaged in discrimination.
Amazon may launch a marketplace where media sites can sell their content to AI companies
A new report claims the e-commerce giant is looking to create a pipeline of licensable content between media publishers and AI companies.
An ice dance duo skated to AI music at the Olympics
Czech ice dancers Katerina Mrazkova and Daniel Mrazek are learning the hard way that LLMs sometimes spit out straight-up plagiarism.
Boston Dynamics CEO Robert Playter steps down after 30 years at the company
Robert Playter announcd he is leaving Boston Dynamics after 30 years at the company in various roles, including six years as CEO.
This Founder Is Taking a Bite Out of the $50 Billion GLP-1 Market By Going Natural
As pharmaceutical companies race to scale synthetic GLP-1s, Evolv is betting that consumers want a natural, orally available version.